Symbols / MCK Stock $760.57 +1.79% McKesson Corporation

Healthcare • Medical Distribution • United States • NYQ
MCK (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Brian S. Tyler Ph.D.
Exch · Country NYQ · United States
Market Cap 91.42B
Enterprise Value 95.97B
Income 4.76B
Sales 403.43B
FCF (ttm) 5.66B
Book/sh -18.10
Cash/sh 33.07
Employees 41,600
Insider 10d —
IPO Nov 10, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 8.26%
P/E 19.80
Forward P/E 15.11
PEG 1.46
P/S 0.23
P/B -42.02
P/C —
EV/EBITDA 13.94
EV/Sales 0.24
Quick Ratio 0.48
Current Ratio 0.85
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 38.41
EPS next Y 50.32
EPS Growth 37.20%
Revenue Growth 6.00%
EPS Gr Q/Q 33.50%
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-07
ROA 4.99%
ROE —
ROIC —
Gross Margin 3.60%
Oper. Margin 2.21%
Profit Margin 1.18%
Shs Outstand 120.20M
Shs Float 120.04M
Insider Own 0.03%
Instit Own 93.37%
Short Float 2.26%
Short Ratio 3.49
Short Interest 2.71M
52W High 999.00
vs 52W High -23.87%
52W Low 637.00
vs 52W Low 19.40%
Beta 0.35
Impl. Vol. 22.00%
Rel Volume 1.78
Avg Volume 861.74K
Volume 1.53M
Target (mean) $949.73
Tgt Median $945.00
Tgt Low $812.00
Tgt High $1,065.00
# Analysts 15
Recom Strong_buy
Prev Close $747.23
Price $760.57
Change 1.79%
About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$949.73
Mean price target
2. Current target
$760.57
Latest analyst target
3. DCF / Fair value
$847.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$760.57
Low
$812.00
High
$1065.00
Mean
$949.73

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-14 main Citigroup Buy → Buy $945
2026-05-12 main Wells Fargo Equal-Weight → Equal-Weight $812
2026-05-08 main UBS Buy → Buy $1050
2026-05-08 main JP Morgan Overweight → Overweight $1015
2026-05-08 main Evercore ISI Group Outperform → Outperform $850
2026-04-28 init William Blair — → Outperform —
2026-04-22 main UBS Buy → Buy $1000
2026-04-08 main Evercore ISI Group Outperform → Outperform $950
2026-04-06 main B of A Securities Buy → Buy $1000
2026-02-18 main Barclays Overweight → Overweight $1050
2026-02-10 main JP Morgan Overweight → Overweight $1107
2026-02-05 main TD Cowen Buy → Buy $1012
2026-02-05 main Wells Fargo Equal-Weight → Equal-Weight $925
2026-02-05 main Mizuho Neutral → Neutral $885
2025-12-09 init Barclays — → Overweight $960
2025-11-10 main Wells Fargo Equal-Weight → Equal-Weight $914
2025-11-06 main UBS Buy → Buy $980
2025-11-06 main Baird Outperform → Outperform $927
2025-11-06 main Morgan Stanley Overweight → Overweight $916
2025-10-27 main UBS Buy → Buy $920
News
RSS: Latest MCK news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 LAU MICHELE Officer — 2,725 $990.00 $2,697,750
2026-02-19 MARTINEZ MARIA N. Director — 349 $939.86 $328,013
2026-02-17 SMITH LEANN B Officer — 190 $945.00 $179,550
2026-02-11 LAU MICHELE Officer — 303 $933.39 $282,817
2026-02-10 SMITH LEANN B Officer — 508 — —
2026-02-09 LAU MICHELE Officer — 4,748 — —
2026-02-06 RUTLEDGE NAPOLEON B JR Officer — 328 $955.00 $313,240
2026-01-05 RODGERS THOMAS L Officer — 276 $816.18 $225,266
2025-11-07 RUTLEDGE NAPOLEON B JR Officer — 329 $861.63 $283,476
2025-08-22 TYLER BRIAN SCOTT Chief Executive Officer — 11,930 $705.63 $8,418,166
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
359,051.00
+16.22%
308,951.00
+11.65%
276,711.00
+4.83%
263,966.00
Operating Revenue
359,051.00
+16.22%
308,951.00
+11.65%
276,711.00
+4.83%
263,966.00
Cost Of Revenue
345,728.00
+16.75%
296,123.00
+12.02%
264,353.00
+5.39%
250,836.00
Reconciled Cost Of Revenue
345,728.00
+16.75%
296,123.00
+12.02%
264,353.00
+5.39%
250,836.00
Gross Profit
13,323.00
+3.86%
12,828.00
+3.80%
12,358.00
-5.88%
13,130.00
Operating Expense
8,507.00
-1.73%
8,657.00
+11.33%
7,776.00
-26.20%
10,537.00
Selling General And Administration
8,507.00
-1.73%
8,657.00
+11.33%
7,776.00
-26.20%
10,537.00
Total Expenses
354,235.00
+16.23%
304,780.00
+12.00%
272,129.00
+4.12%
261,373.00
Operating Income
4,816.00
+15.46%
4,171.00
-8.97%
4,582.00
+76.71%
2,593.00
Total Operating Income As Reported
4,422.00
+13.12%
3,909.00
-10.77%
4,381.00
+114.97%
2,038.00
EBITDA
5,260.00
+12.49%
4,676.00
-14.76%
5,486.00
+91.42%
2,866.00
Normalized EBITDA
5,587.00
+12.69%
4,958.00
-11.08%
5,576.00
+60.65%
3,471.00
Reconciled Depreciation
636.00
+0.16%
635.00
+4.44%
608.00
-20.00%
760.00
EBIT
4,624.00
+14.43%
4,041.00
-17.16%
4,878.00
+131.62%
2,106.00
Total Unusual Items
-327.00
-15.96%
-282.00
-213.33%
-90.00
+85.12%
-605.00
Total Unusual Items Excluding Goodwill
-327.00
-15.96%
-282.00
-213.33%
-90.00
+85.12%
-605.00
Special Income Charges
-394.00
-50.38%
-262.00
-30.35%
-201.00
+73.06%
-746.00
Other Special Charges
108.00
-26.53%
147.00
+1937.50%
-8.00
-101.72%
465.00
Impairment Of Capital Assets
—
—
0.00
-100.00%
36.00
Restructuring And Mergern Acquisition
286.00
+148.70%
115.00
-44.98%
209.00
-25.62%
281.00
Net Income
3,295.00
+9.76%
3,002.00
-15.67%
3,560.00
+219.57%
1,114.00
Pretax Income
4,359.00
+15.04%
3,789.00
-18.16%
4,630.00
+140.15%
1,928.00
Net Non Operating Interest Income Expense
-92.00
+31.34%
-134.00
+4.96%
-141.00
+16.07%
-168.00
Interest Expense Non Operating
265.00
+5.16%
252.00
+1.61%
248.00
+39.33%
178.00
Net Interest Income
-92.00
+31.34%
-134.00
+4.96%
-141.00
+16.07%
-168.00
Interest Expense
265.00
+5.16%
252.00
+1.61%
248.00
+39.33%
178.00
Interest Income Non Operating
173.00
+46.61%
118.00
+10.28%
107.00
+970.00%
10.00
Interest Income
173.00
+46.61%
118.00
+10.28%
107.00
+970.00%
10.00
Other Income Expense
-365.00
-47.18%
-248.00
-231.22%
189.00
+138.03%
-497.00
Other Non Operating Income Expenses
-38.00
-211.76%
34.00
-87.81%
279.00
+158.33%
108.00
Gain On Sale Of Security
67.00
+435.00%
-20.00
-118.02%
111.00
-21.28%
141.00
Tax Provision
878.00
+39.59%
629.00
-30.50%
905.00
+42.30%
636.00
Tax Rate For Calcs
0.00
+21.08%
0.00
-14.87%
0.00
-40.91%
0.00
Tax Effect Of Unusual Items
-65.73
-40.41%
-46.81
-166.74%
-17.55
+91.21%
-199.65
Net Income Including Noncontrolling Interests
3,481.00
+10.16%
3,160.00
-15.10%
3,722.00
+189.20%
1,287.00
Net Income From Continuing Operation Net Minority Interest
3,295.00
+9.76%
3,002.00
-15.75%
3,563.00
+218.41%
1,119.00
Net Income From Continuing And Discontinued Operation
3,295.00
+9.76%
3,002.00
-15.67%
3,560.00
+219.57%
1,114.00
Net Income Continuous Operations
3,481.00
+10.16%
3,160.00
-15.17%
3,725.00
+188.31%
1,292.00
Net Income Discontinuous Operations
0.00
0.00
+100.00%
-3.00
+40.00%
-5.00
Minority Interests
-186.00
-17.72%
-158.00
+2.47%
-162.00
+6.36%
-173.00
Normalized Income
3,556.27
+9.86%
3,237.19
-10.95%
3,635.45
+138.49%
1,524.35
Net Income Common Stockholders
3,295.00
+9.76%
3,002.00
-15.67%
3,560.00
+219.57%
1,114.00
Diluted EPS
25.72
+14.87%
22.39
-10.55%
25.03
+246.20%
7.23
Basic EPS
25.86
+14.73%
22.54
-10.66%
25.23
+244.67%
7.32
Basic Average Shares
127.40
-4.35%
133.20
-5.60%
141.10
-7.35%
152.30
Diluted Average Shares
128.10
-4.47%
134.10
-5.70%
142.20
-7.72%
154.10
Diluted NI Availto Com Stockholders
3,295.00
+9.76%
3,002.00
-15.67%
3,560.00
+219.57%
1,114.00
Earnings From Equity Interest
—
—
—
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
75,140.00
+11.41%
67,443.00
+8.22%
62,320.00
-1.55%
63,298.00
Current Assets
55,398.00
+15.48%
47,970.00
+8.30%
44,292.00
-4.19%
46,231.00
Cash Cash Equivalents And Short Term Investments
5,691.00
+24.18%
4,583.00
-2.03%
4,678.00
+32.45%
3,532.00
Cash And Cash Equivalents
5,691.00
+24.18%
4,583.00
-2.03%
4,678.00
+32.45%
3,532.00
Receivables
25,643.00
+18.60%
21,622.00
+11.40%
19,410.00
+4.45%
18,583.00
Accounts Receivable
22,281.00
+14.62%
19,439.00
+13.28%
17,160.00
+4.39%
16,438.00
Receivables Adjustments Allowances
-500.00
+45.71%
-921.00
-482.91%
-158.00
-9.72%
-144.00
Other Receivables
3,862.00
+24.42%
3,104.00
+28.90%
2,408.00
+5.20%
2,289.00
Inventory
23,001.00
+8.81%
21,139.00
+7.35%
19,691.00
+5.29%
18,702.00
Prepaid Assets
—
—
—
898.00
Assets Held For Sale Current
—
—
17.00
-99.62%
4,516.00
Other Current Assets
1,063.00
+69.81%
626.00
+22.03%
513.00
-42.87%
898.00
Total Non Current Assets
19,742.00
+1.38%
19,473.00
+8.02%
18,028.00
+5.63%
17,067.00
Net PPE
4,284.00
+5.91%
4,045.00
+6.11%
3,812.00
+4.73%
3,640.00
Gross PPE
6,813.00
+4.62%
6,512.00
+7.76%
6,043.00
+7.26%
5,634.00
Accumulated Depreciation
-2,529.00
-2.51%
-2,467.00
-10.58%
-2,231.00
-11.89%
-1,994.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
104.00
-4.59%
109.00
+0.00%
109.00
+4.81%
104.00
Buildings And Improvements
1,433.00
-3.31%
1,482.00
+4.88%
1,413.00
+6.16%
1,331.00
Machinery Furniture Equipment
2,772.00
+0.76%
2,751.00
+5.69%
2,603.00
+11.33%
2,338.00
Construction In Progress
722.00
+63.72%
441.00
+55.83%
283.00
-9.58%
313.00
Other Properties
1,782.00
+3.07%
1,729.00
+5.75%
1,635.00
+5.62%
1,548.00
Goodwill And Other Intangible Assets
11,486.00
-6.18%
12,242.00
+0.15%
12,224.00
+6.20%
11,510.00
Goodwill
10,022.00
-1.09%
10,132.00
+1.86%
9,947.00
+5.25%
9,451.00
Other Intangible Assets
1,464.00
-30.62%
2,110.00
-7.33%
2,277.00
+10.59%
2,059.00
Other Non Current Assets
3,972.00
+24.67%
3,186.00
+59.94%
1,992.00
+3.91%
1,917.00
Total Liabilities Net Minority Interest
76,834.00
+11.29%
69,042.00
+8.20%
63,810.00
-1.97%
65,090.00
Current Liabilities
61,604.00
+17.66%
52,357.00
+9.17%
47,957.00
-1.05%
48,466.00
Payables And Accrued Expenses
60,155.00
+15.66%
52,012.00
+11.40%
46,690.00
+9.53%
42,629.00
Payables
55,330.00
+17.48%
47,097.00
+10.84%
42,490.00
+11.56%
38,086.00
Accounts Payable
55,330.00
+17.48%
47,097.00
+10.84%
42,490.00
+11.56%
38,086.00
Current Accrued Expenses
4,825.00
-1.83%
4,915.00
+17.02%
4,200.00
-7.55%
4,543.00
Current Debt And Capital Lease Obligation
1,449.00
+320.00%
345.00
-72.77%
1,267.00
+15.60%
1,096.00
Current Debt
1,191.00
+2282.00%
50.00
-94.83%
968.00
+21.15%
799.00
Other Current Borrowings
1,191.00
+2282.00%
50.00
-94.83%
968.00
+21.15%
799.00
Current Capital Lease Obligation
258.00
-12.54%
295.00
-1.34%
299.00
+0.67%
297.00
Other Current Liabilities
—
—
5.00
-99.89%
4,741.00
Total Non Current Liabilities Net Minority Interest
15,230.00
-8.72%
16,685.00
+5.25%
15,853.00
-4.64%
16,624.00
Long Term Debt And Capital Lease Obligation
5,941.00
-15.67%
7,045.00
+16.87%
6,028.00
-6.48%
6,446.00
Long Term Debt
4,463.00
-20.00%
5,579.00
+20.60%
4,626.00
-8.94%
5,080.00
Long Term Capital Lease Obligation
1,478.00
+0.82%
1,466.00
+4.56%
1,402.00
+2.64%
1,366.00
Non Current Deferred Liabilities
1,029.00
+12.21%
917.00
-33.89%
1,387.00
-2.19%
1,418.00
Non Current Deferred Taxes Liabilities
1,029.00
+12.21%
917.00
-33.89%
1,387.00
-2.19%
1,418.00
Other Non Current Liabilities
8,260.00
-5.31%
8,723.00
+3.38%
8,438.00
-3.68%
8,760.00
Stockholders Equity
-2,074.00
-5.23%
-1,971.00
-6.14%
-1,857.00
+18.27%
-2,272.00
Common Stock Equity
-2,074.00
-5.23%
-1,971.00
-6.14%
-1,857.00
+18.27%
-2,272.00
Capital Stock
3.00
+0.00%
3.00
+0.00%
3.00
+50.00%
2.00
Common Stock
3.00
+0.00%
3.00
+0.00%
3.00
+50.00%
2.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
279.00
+0.21%
278.41
+0.51%
277.00
+0.73%
275.00
Ordinary Shares Number
125.00
-4.15%
130.41
-4.11%
136.00
-6.21%
145.00
Treasury Shares Number
154.00
+4.05%
148.00
+4.96%
141.00
+8.46%
130.00
Additional Paid In Capital
8,373.00
+4.04%
8,048.00
+3.89%
7,747.00
+6.49%
7,275.00
Retained Earnings
17,921.00
+19.65%
14,978.00
+21.82%
12,295.00
+36.16%
9,030.00
Gains Losses Not Affecting Retained Earnings
-932.00
-5.79%
-881.00
+2.65%
-905.00
+41.00%
-1,534.00
Treasury Stock
27,439.00
+13.77%
24,119.00
+14.87%
20,997.00
+23.19%
17,045.00
Minority Interest
380.00
+2.15%
372.00
+1.36%
367.00
-23.54%
480.00
Other Equity Adjustments
-932.00
-5.79%
-881.00
+2.65%
-905.00
+41.00%
-1,534.00
Total Equity Gross Minority Interest
-1,694.00
-5.94%
-1,599.00
-7.32%
-1,490.00
+16.85%
-1,792.00
Total Capitalization
2,389.00
-33.79%
3,608.00
+30.30%
2,769.00
-1.39%
2,808.00
Working Capital
-6,206.00
-41.46%
-4,387.00
-19.70%
-3,665.00
-63.98%
-2,235.00
Invested Capital
3,580.00
-2.13%
3,658.00
-2.11%
3,737.00
+3.60%
3,607.00
Total Debt
7,390.00
+0.00%
7,390.00
+1.30%
7,295.00
-3.27%
7,542.00
Net Debt
—
1,046.00
+14.19%
916.00
-60.97%
2,347.00
Capital Lease Obligations
1,736.00
-1.42%
1,761.00
+3.53%
1,701.00
+2.29%
1,663.00
Net Tangible Assets
-13,560.00
+4.59%
-14,213.00
-0.94%
-14,081.00
-2.17%
-13,782.00
Tangible Book Value
-13,560.00
+4.59%
-14,213.00
-0.94%
-14,081.00
-2.17%
-13,782.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
6,085.00
+41.05%
4,314.00
-16.38%
5,159.00
+16.35%
4,434.00
Cash Flow From Continuing Operating Activities
6,085.00
+41.05%
4,314.00
-16.38%
5,159.00
+16.35%
4,434.00
Net Income From Continuing Operations
3,481.00
+10.16%
3,160.00
-15.10%
3,722.00
+189.20%
1,287.00
Depreciation Amortization Depletion
636.00
+0.16%
635.00
+4.44%
608.00
-20.00%
760.00
Depreciation
242.00
-4.35%
253.00
+2.02%
248.00
-11.11%
279.00
Amortization Cash Flow
394.00
+3.14%
382.00
+6.11%
360.00
-25.16%
481.00
Depreciation And Amortization
636.00
+0.16%
635.00
+4.44%
608.00
-20.00%
760.00
Amortization Of Intangibles
394.00
+3.14%
382.00
+6.11%
360.00
-25.16%
481.00
Other Non Cash Items
470.00
+37.83%
341.00
-39.00%
559.00
-37.61%
896.00
Provisionand Write Offof Assets
-130.00
-115.87%
819.00
+1720.00%
45.00
+55.17%
29.00
Asset Impairment Charge
98.00
+127.91%
43.00
-40.28%
72.00
-58.86%
175.00
Deferred Tax
-110.00
+81.76%
-603.00
-2915.00%
-20.00
-158.82%
34.00
Deferred Income Tax
-110.00
+81.76%
-603.00
-2915.00%
-20.00
-158.82%
34.00
Operating Gains Losses
485.00
+2952.94%
-17.00
+91.94%
-211.00
-115.32%
1,377.00
Change In Working Capital
1,155.00
+1904.69%
-64.00
-116.67%
384.00
+409.68%
-124.00
Change In Receivables
-3,935.00
-33.21%
-2,954.00
-173.01%
-1,082.00
+41.29%
-1,843.00
Change In Inventory
-2,270.00
-75.43%
-1,294.00
-2.78%
-1,259.00
-7.70%
-1,169.00
Change In Payables And Accrued Expense
8,301.00
+80.97%
4,587.00
+21.09%
3,788.00
+35.19%
2,802.00
Change In Payable
8,301.00
+80.97%
4,587.00
+21.09%
3,788.00
+35.19%
2,802.00
Change In Other Working Capital
-136.00
-141.09%
331.00
-8.82%
363.00
+49.38%
243.00
Change In Other Current Liabilities
-805.00
-9.67%
-734.00
+48.53%
-1,426.00
-808.28%
-157.00
Investing Cash Flow
-733.00
+31.62%
-1,072.00
-97.79%
-542.00
-508.99%
-89.00
Cash Flow From Continuing Investing Activities
-733.00
+31.62%
-1,072.00
-97.79%
-542.00
-508.99%
-89.00
Net PPE Purchase And Sale
-537.00
-24.59%
-431.00
-10.51%
-390.00
-0.52%
-388.00
Purchase Of PPE
-537.00
-24.59%
-431.00
-10.51%
-390.00
-0.52%
-388.00
Capital Expenditure
-859.00
-25.04%
-687.00
-23.12%
-558.00
-4.30%
-535.00
Capital Expenditure Reported
-322.00
-25.78%
-256.00
-52.38%
-168.00
-14.29%
-147.00
Net Business Purchase And Sale
155.00
+168.89%
-225.00
-207.14%
210.00
-63.29%
572.00
Purchase Of Business
-24.00
+91.18%
-272.00
+68.63%
-867.00
-14350.00%
-6.00
Gain Loss On Sale Of Business
485.00
+2952.94%
-17.00
+91.94%
-211.00
-115.32%
1,377.00
Net Other Investing Changes
-29.00
+81.88%
-160.00
+17.53%
-194.00
-53.97%
-126.00
Financing Cash Flow
-3,965.00
-18.64%
-3,342.00
+23.49%
-4,368.00
+30.90%
-6,321.00
Cash Flow From Continuing Financing Activities
-3,965.00
-18.64%
-3,342.00
+23.49%
-4,368.00
+30.90%
-6,321.00
Issuance Of Debt
15,584.00
-25.63%
20,955.00
+121.82%
9,447.00
-19.19%
11,690.00
Repayment Of Debt
-15,605.00
+25.33%
-20,899.00
-114.92%
-9,724.00
+24.27%
-12,840.00
Long Term Debt Issuance
498.00
-49.75%
991.00
-0.60%
997.00
+100.20%
498.00
Long Term Debt Payments
-519.00
+44.49%
-935.00
+26.61%
-1,274.00
+22.69%
-1,648.00
Net Long Term Debt Issuance
-21.00
-137.50%
56.00
+120.22%
-277.00
+75.91%
-1,150.00
Short Term Debt Issuance
15,086.00
-24.43%
19,964.00
+136.26%
8,450.00
-24.50%
11,192.00
Short Term Debt Payments
-15,086.00
+24.43%
-19,964.00
-136.26%
-8,450.00
+24.50%
-11,192.00
Net Short Term Debt Issuance
0.00
0.00
0.00
0.00
Net Common Stock Issuance
-3,045.00
-4.68%
-2,909.00
+16.29%
-3,475.00
-5.43%
-3,296.00
Common Stock Payments
-3,146.00
-4.00%
-3,025.00
+16.85%
-3,638.00
-3.47%
-3,516.00
Common Stock Dividend Paid
-345.00
-9.87%
-314.00
-7.53%
-292.00
-5.42%
-277.00
Cash Dividends Paid
-345.00
-9.87%
-314.00
-7.53%
-292.00
-5.42%
-277.00
Repurchase Of Capital Stock
-3,146.00
-4.00%
-3,025.00
+16.85%
-3,638.00
-3.47%
-3,516.00
Net Other Financing Charges
-554.00
-216.57%
-175.00
+45.99%
-324.00
+79.72%
-1,598.00
Changes In Cash
1,387.00
+1487.00%
-100.00
-113.91%
719.00
+128.58%
-2,516.00
Effect Of Exchange Rate Changes
-16.00
-366.67%
6.00
-76.00%
25.00
-54.55%
55.00
Beginning Cash Position
4,585.00
-2.01%
4,679.00
+18.91%
3,935.00
-38.48%
6,396.00
End Cash Position
5,691.00
+24.18%
4,583.00
-2.03%
4,678.00
+32.45%
3,532.00
Free Cash Flow
5,226.00
+44.09%
3,627.00
-21.17%
4,601.00
+18.00%
3,899.00
Interest Paid Supplemental Data
273.00
+16.67%
234.00
+4.46%
224.00
+20.43%
186.00
Income Tax Paid Supplemental Data
1,124.00
+24.75%
901.00
+60.32%
562.00
+56.55%
359.00
Common Stock Issuance
101.00
-12.93%
116.00
-28.83%
163.00
-25.91%
220.00
Earnings Losses From Equity Investments
—
—
—
0.00
Issuance Of Capital Stock
101.00
-12.93%
116.00
-28.83%
163.00
-25.91%
220.00
Other Cash Adjustment Inside Changein Cash
0.00
0.00
-100.00%
470.00
+187.04%
-540.00
Other Cash Adjustment Outside Changein Cash
-265.00
-13150.00%
-2.00
-100.00%
-1.00
+99.75%
-403.00
Sale Of Business
179.00
+280.85%
47.00
-95.64%
1,077.00
+86.33%
578.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category